Changchun High-tech (000661.SZ): GenSci134 Injection approved for domestic production of drug for clinical trial registration.

Zhijing Financial APP News, Changchun High-tech (000661.SZ) announced that its subsidiary Changchun Jin Sai Pharmaceutical Co., Ltd. (referred to as "Jin Sai Pharmaceutical") has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. The domestic production drug registration clinical trial application for GenSci 134 injection solution of Jin Sai Pharmaceutical has been approved.